Observations placeholder
Humalog
Identifier
005503
Type of Spiritual Experience
Background
A description of the experience
Insulin lispro - marketed as "Humalog" ; is a fast acting insulin analogue; it was the first insulin analogue, and is similar to insulin aspart. It was engineered through recombinant DNA technology. “Insulin lispro has one primary advantage over regular insulin for postprandial glucose control. It has a shortened delay of onset, allowing slightly more flexibility than regular insulin, which requires a longer waiting period before starting a meal after injection. Both preparations should be coupled with a longer acting insulin for good glycemic control”.